Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis

R Suri, R Grieve, C Normand, C Metcalfe, S Thompson, C Wallis, A Bush

Research output: Contribution to journalArticle (Academic Journal)peer-review

42 Citations (Scopus)

Abstract

Daily recombinant human deoxyribonuclease (rhDNase) is an established but expensive treatment in cystic fibrosis (CF). An alternative lower cost therapy is hypertonic saline (HS), which has been shown to improve lung function in short term studies. This study compares the costs and consequences of daily rhDNase with alternate day rhDNase and HS in children with CF.
Original languageEnglish
Pages (from-to)841-6
Number of pages6
JournalThorax
Volume57
Issue number10
Publication statusPublished - 2002

Fingerprint Dive into the research topics of 'Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis'. Together they form a unique fingerprint.

Cite this